25.41
price down icon5.85%   -1.685
 
loading

Oculis Holding Ag Aktie (OCS) Neueste Nachrichten

pulisher
Mar 12, 2026

Risk Off: Can Oculis Holding AG beat the S P 500Portfolio Risk Report & Weekly Setup with High ROI Potential - baoquankhu1.vn

Mar 12, 2026
pulisher
Mar 12, 2026

Avoiding Lag: Real-Time Signals in (OCS) Movement - Stock Traders Daily

Mar 12, 2026
pulisher
Mar 11, 2026

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - marketscreener.com

Mar 11, 2026
pulisher
Mar 11, 2026

Aug Opening: What is the implied volatility of Oculis Holding AG Equity WarrantWeekly Investment Report & Safe Capital Investment Plans - baoquankhu1.vn

Mar 11, 2026
pulisher
Mar 11, 2026

H.C. Wainwright raises Oculis stock price target to $44 on trial progress - Investing.com Nigeria

Mar 11, 2026
pulisher
Mar 10, 2026

Biopharma companies hire new legal executives - BioXconomy

Mar 10, 2026
pulisher
Mar 10, 2026

Oculis (NASDAQ:OCS) Sees Large Volume IncreaseHere's What Happened - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

OCS: Late-stage pipeline targets DME, dry eye, and neuroprotection, with major data readouts in 2024 - TradingView

Mar 10, 2026
pulisher
Mar 09, 2026

A Look At Oculis Holding (OCS) Valuation After Breakthrough Therapy Status And Q4 2025 Update - Sahm

Mar 09, 2026
pulisher
Mar 09, 2026

Oculis (OCS) – Research Analysts’ Recent Ratings Updates - Defense World

Mar 09, 2026
pulisher
Mar 08, 2026

Oculis Holding (NasdaqGM:OCS) Valuation Check After Strong Three Year Gains And Recent Share Price Pullback - Yahoo Finance

Mar 08, 2026
pulisher
Mar 07, 2026

Oculis (NASDAQ:OCS) Downgraded by Wall Street Zen to "Sell" - MarketBeat

Mar 07, 2026
pulisher
Mar 07, 2026

Lifesci Capital Has Negative Estimate for Oculis Q1 Earnings - Defense World

Mar 07, 2026
pulisher
Mar 06, 2026

Lifesci Capital Estimates Oculis' Q1 Earnings (NASDAQ:OCS) - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

HC Wainwright Weighs in on Oculis' Q1 Earnings (NASDAQ:OCS) - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Why Oculis (OCS) Is Down 6.2% After New Equity Programs To Fund Late-Stage Trials - Sahm

Mar 06, 2026
pulisher
Mar 05, 2026

Oculis (NASDAQ:OCS) Releases Quarterly Earnings Results, Misses Expectations By $0.08 EPS - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

H.C. Wainwright raises Oculis stock price target to $44 on trial progress By Investing.com - Investing.com South Africa

Mar 05, 2026
pulisher
Mar 05, 2026

Oculis Holding AG to Showcase Late-Stage Portfolio and Strategic Developments at March Investor Conferences - Quiver Quantitative

Mar 05, 2026
pulisher
Mar 05, 2026

Oculis Publishes 2025 Consolidated Financial Statements - Yahoo Finance

Mar 05, 2026
pulisher
Mar 05, 2026

Oculis Holding AG renews $100 million at-the-market offering program - Investing.com Australia

Mar 05, 2026
pulisher
Mar 05, 2026

Stifel raises Oculis stock price target to $50 on pipeline progress - Investing.com Nigeria

Mar 05, 2026
pulisher
Mar 04, 2026

Oculis Holding AG renews $100 million at-the-market offering program By Investing.com - Investing.com South Africa

Mar 04, 2026
pulisher
Mar 04, 2026

Oculis Files 2025 Financials and Renews $100 Million ATM Program - TipRanks

Mar 04, 2026
pulisher
Mar 04, 2026

Oculis Holding (NASDAQ: OCS) widens loss but ends 2025 with strong cash and $100m ATM capacity - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Oculis price target raised to $44 from $42 at H.C. Wainwright - TipRanks

Mar 04, 2026
pulisher
Mar 04, 2026

Oculis (NASDAQ: OCS) 2025 20-F details losses, cash and trials - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

HC Wainwright Issues Positive Forecast for Oculis (NASDAQ:OCS) Stock Price - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Oculis (NASDAQ:OCS) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Chardan Raises Price Target on Oculis Holding to $53 From $51, Keeps Buy Rating - marketscreener.com

Mar 04, 2026
pulisher
Mar 04, 2026

Oculis Holding's Q4 Net Loss Narrows; Plans Phase 3 Trial Readouts For OCS-01 In Q2,2026 - Nasdaq

Mar 04, 2026
pulisher
Mar 04, 2026

Oculis Reports Q4 and Full-Year 2025 Results, Shares Update - InvisionMag.com

Mar 04, 2026
pulisher
Mar 03, 2026

Oculis Posts 2025 Results, Extends Cash Runway and Advances Late-Stage Ophthalmology Pipeline - TipRanks

Mar 03, 2026
pulisher
Mar 03, 2026

Oculis Holding AG (OCS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 03, 2026
pulisher
Mar 03, 2026

Oculis reports Q4 EPS (CHF 0.42c) vs. (CHF 0.67) last year - TipRanks

Mar 03, 2026
pulisher
Mar 03, 2026

Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update - The Manila Times

Mar 03, 2026
pulisher
Mar 03, 2026

[6-K] Oculis Holding AG Current Report (Foreign Issuer) | OCS SEC FilingForm 6-K - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Eye drug firm Oculis eyes 3 major 2026 vision milestones after $119M loss - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Oculis (OCS) to Release Quarterly Earnings on Tuesday - MarketBeat

Mar 03, 2026
pulisher
Mar 02, 2026

Oculis Holding AG (NASDAQ:OCS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

Earnings To Watch: Oculis Holding AG (OCS) Reports Q4 2025 Resul - GuruFocus

Mar 02, 2026
pulisher
Feb 28, 2026

Discipline and Rules-Based Execution in OCS Response - Stock Traders Daily

Feb 28, 2026
pulisher
Feb 27, 2026

Oculis Holding AG expected to post a loss of 42 rappen a shareEarnings Preview - TradingView

Feb 27, 2026
pulisher
Feb 26, 2026

Oculis (NASDAQ:OCS) Sets New 12-Month HighHere's What Happened - MarketBeat

Feb 26, 2026
pulisher
Feb 24, 2026

Bull Bear: Can Oculis Holding AG continue delivering strong returnsJuly 2025 Macro Moves & Community Trade Idea Sharing Platform - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 24, 2026

Big Picture: Will Oculis Holding AG benefit from green energy policiesTrade Risk Report & Fast Entry Momentum Alerts - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 23, 2026

Will Oculis Holding AG benefit from green energy policiesMarket Activity Recap & Fast Gain Stock Tips - mfd.ru

Feb 23, 2026
pulisher
Feb 21, 2026

Oculis Holding AG (OCS) Investor Outlook: Analyst Ratings Signal a 59.98% Upside Potential - DirectorsTalk Interviews

Feb 21, 2026
pulisher
Feb 20, 2026

Fund Flows: Whats the profit margin of Oculis Holding AG Equity Warrant2025 Top Decliners & Low Risk High Win Rate Picks - baoquankhu1.vn

Feb 20, 2026
pulisher
Feb 20, 2026

Oculis (NASDAQ:OCS) Hits New 1-Year HighHere's Why - MarketBeat

Feb 20, 2026
pulisher
Feb 20, 2026

Aug EndMonth: Can Oculis Holding AG beat the S P 5002025 Major Catalysts & Daily Risk Controlled Trade Plans - baoquankhu1.vn

Feb 20, 2026
pulisher
Feb 18, 2026

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated - Yahoo Finance UK

Feb 18, 2026
pulisher
Feb 18, 2026

Behavioral Patterns of OCS and Institutional Flows - Stock Traders Daily

Feb 18, 2026
$45.87
price up icon 0.18%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$139.44
price down icon 0.28%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):